Treatment of refractory hypocomplementaemic urticarial vasculitis syndrome progressing to systemic lupus erythematosus with belimumab.

Valor-Méndez L, Schett G, Manger B (2022)

Publication Type: Journal article, Letter

Publication year: 2022

Journal

Clinical and Experimental Rheumatology Clinical and Experimental Rheumatology Sas

Book Volume: 40

Pages Range: 854-855

Journal Issue: 4

DOI: 10.55563/clinexprheumatol/m9dexe

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III Bernhard Manger Professur für Rheumatologie und Klinische Immunologie

How to cite

APA:

Valor-Méndez, L., Schett, G., & Manger, B. (2022). Treatment of refractory hypocomplementaemic urticarial vasculitis syndrome progressing to systemic lupus erythematosus with belimumab. Clinical and Experimental Rheumatology, 40(4), 854-855. https://doi.org/10.55563/clinexprheumatol/m9dexe

MLA:

Valor-Méndez, Larissa, Georg Schett, and Bernhard Manger. "Treatment of refractory hypocomplementaemic urticarial vasculitis syndrome progressing to systemic lupus erythematosus with belimumab." Clinical and Experimental Rheumatology 40.4 (2022): 854-855.

BibTeX: Download